The process of identifying promising small molecule drug candidates that target cancer checkpoints may become faster and smarter through virtual screening, according to Weill Cornell Medicine researchers.
Weill Cornell Medicine researchers have received a five-year, $6.2 million grant from the National Institute on Aging, part of the National Institutes of Health, to build a portable, high-resolution Positron Emission Tomography scanner that can detect the earliest stages of Alzheimer’s disease.
Dr. Chani Traube, professor of pediatrics at Weill Cornell Medicine, has been awarded a $3.4 million grant from the National Institutes of Health for a clinical trial called Optimizing Pain Treatment in Children on Mechanical ventilation.
Investigators from Weill Cornell Medicine have discovered a defense mechanism that protects skin cancer cells from oxidative stress and helps them spread.
Professors Dr. Silvia Formenti and Dr. Massimo Loda have been elected to the National Academy of Medicine, in recognition of outstanding professional achievement and major contributions to the advancement of the medical sciences.
The fireside chat was part of a two-day visit by Dr. Robert M. Califf, commissioner of the U.S. Food and Drug Administration, who focused on medicine and health care innovations.
